128 related articles for article (PubMed ID: 17460357)
21. Gabapentin blocks methamphetamine-induced sensitization and conditioned place preference via inhibition of α₂/δ-1 subunits of the voltage-gated calcium channels.
Kurokawa K; Shibasaki M; Mizuno K; Ohkuma S
Neuroscience; 2011 Mar; 176():328-35. PubMed ID: 21182903
[TBL] [Abstract][Full Text] [Related]
22. Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine: Implications for their antiaddictive properties.
Szumlinski KK; Haskew RE; Balogun MY; Maisonneuve IM; Glick SD
Pharmacol Biochem Behav; 2001; 69(3-4):485-91. PubMed ID: 11509208
[TBL] [Abstract][Full Text] [Related]
23. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
24. Behavioral sensitization induced by methamphetamine causes differential alterations in gene expression and histone acetylation of the prefrontal cortex in rats.
Li H; Chen JA; Ding QZ; Lu GY; Wu N; Su RB; Li F; Li J
BMC Neurosci; 2021 Apr; 22(1):24. PubMed ID: 33823794
[TBL] [Abstract][Full Text] [Related]
25. Effect of the protein kinase C inhibitor, staurosporine, on the high dose of methamphetamine-induced behavioral sensitization to dizocilpine (MK-801).
Fang YR; Abekawa T; Li XB; Wang ZC; Inoue T; Koyama T
Psychopharmacology (Berl); 2005 Jun; 180(1):100-6. PubMed ID: 15682296
[TBL] [Abstract][Full Text] [Related]
26. The altered disposition of methamphetamine in the model of methamphetamine-induced neurotoxicity.
Kitaichi K; Ito Y; Fukuda M; Aoyama N; Nakayama H; Takagi K; Hasegawa T
Ann N Y Acad Sci; 2004 Oct; 1025():248-56. PubMed ID: 15542724
[TBL] [Abstract][Full Text] [Related]
27. mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization.
Shen X; Purser C; Tien LT; Chiu CT; Paul IA; Baker R; Loh HH; Ho IK; Ma T
J Neurosci Res; 2010 Aug; 88(10):2294-302. PubMed ID: 20209629
[TBL] [Abstract][Full Text] [Related]
28. Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.
Igari M; Shen HW; Hagino Y; Fukushima S; Kasahara Y; Lesch KP; Murphy DL; Hall FS; Uhl GR; Ikeda K; Yaegashi N; Sora I
Behav Pharmacol; 2015 Feb; 26(1-2):167-79. PubMed ID: 25485646
[TBL] [Abstract][Full Text] [Related]
29. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice.
Ago Y; Nakamura S; Kajita N; Uda M; Hashimoto H; Baba A; Matsuda T
Synapse; 2007 Sep; 61(9):757-63. PubMed ID: 17568413
[TBL] [Abstract][Full Text] [Related]
30. Neonatal exposure to lipopolysaccharide enhances methamphetamine-induced reinstated behavioral sensitization in adult rats.
Tien LT; Cai Z; Rhodes PG; Fan LW
Behav Brain Res; 2011 Oct; 224(1):166-73. PubMed ID: 21669234
[TBL] [Abstract][Full Text] [Related]
31. Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release.
Mizoguchi H; Yamada K; Mouri A; Niwa M; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
J Neurochem; 2007 Sep; 102(5):1548-1560. PubMed ID: 17472698
[TBL] [Abstract][Full Text] [Related]
32. Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol.
Nagai T; Takuma K; Dohniwa M; Ibi D; Mizoguchi H; Kamei H; Nabeshima T; Yamada K
Psychopharmacology (Berl); 2007 Sep; 194(1):21-32. PubMed ID: 17514479
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice.
Maeda T; Kiguchi N; Fukazawa Y; Yamamoto A; Ozaki M; Kishioka S
Neuropsychopharmacology; 2007 May; 32(5):1133-40. PubMed ID: 17019405
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens.
Sim MS; Soga T; Pandy V; Wu YS; Parhar IS; Mohamed Z
Metab Brain Dis; 2017 Dec; 32(6):1767-1783. PubMed ID: 28681200
[TBL] [Abstract][Full Text] [Related]
35. Effects of environmental enrichment during induction of methamphetamine dependence on the behavioral withdrawal symptoms in rats.
Hajheidari S; Miladi-Gorji H; Bigdeli I
Neurosci Lett; 2015 Sep; 605():39-43. PubMed ID: 26275348
[TBL] [Abstract][Full Text] [Related]
36. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice.
Fujii H; Ishihama T; Ago Y; Shintani N; Kakuda M; Hashimoto H; Baba A; Matsuda T
Peptides; 2007 Sep; 28(9):1674-9. PubMed ID: 17658665
[TBL] [Abstract][Full Text] [Related]
37. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
[TBL] [Abstract][Full Text] [Related]
38. Intravenous Prenatal Nicotine Exposure Alters METH-Induced Hyperactivity, Conditioned Hyperactivity, and BDNF in Adult Rat Offspring.
Lacy RT; Brown RW; Morgan AJ; Mactutus CF; Harrod SB
Dev Neurosci; 2016; 38(3):171-185. PubMed ID: 27287203
[TBL] [Abstract][Full Text] [Related]
39. Blockade of M1 muscarinic acetylcholine receptors modulates the methamphetamine-induced psychomotor stimulant effect.
Lee KW; Tian YH; You IJ; Kwon SH; Ha RR; Lee SY; Kim HC; Jang CG
Neuroscience; 2008 Jun; 153(4):1235-44. PubMed ID: 18455881
[TBL] [Abstract][Full Text] [Related]
40. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
